|
|
|
Volumn 11, Issue 10, 2008, Pages 705-709
|
|
Drug discovery and development of innovative therapeutics - IBC's 13th annual world congress. Approaches to cancer therapy
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
5 (4 BROMO 2 CHLOROANILINO) 4 FLUORO 1 METHYL 1H BENZIMIDAZOLE 6 CARBOHYDROXAMIC ACID 2 HYDROXYETHYL ESTER;
A 443654;
ALN VSP 01;
AMG 102;
ANTIBODY CONJUGATE;
ANTINEOPLASTIC AGENT;
AP 24534;
ARF PROTEIN;
ARQ 197;
AZD 1480;
BEVACIZUMAB;
BHQ 880;
BORTEZOMIB;
CNF 1010;
ELESCLOMOL;
EPIDERMAL GROWTH FACTOR RECEPTOR;
GC 1008;
IPI 926;
MK 0752;
NVP AUY 922;
PACLITAXEL;
PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;
RIBOZYME;
SNX 5422;
STA 4783;
TANESPIMYCIN;
TEMOZOLOMIDE;
TEMSIROLIMUS;
TRASTUZUMAB;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
BRAIN CANCER;
BREAST CANCER;
CANCER RESEARCH;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG RESEARCH;
HUMAN;
NONHUMAN;
PROSTATE CANCER;
ANIMALS;
ANTINEOPLASTIC AGENTS;
BIOLOGICAL PRODUCTS;
BRAIN NEOPLASMS;
BREAST NEOPLASMS;
DRUG DELIVERY SYSTEMS;
DRUG DESIGN;
DRUGS, INVESTIGATIONAL;
FEMALE;
HUMANS;
MALE;
NEOPLASMS;
PROSTATIC NEOPLASMS;
TUMOR MARKERS, BIOLOGICAL;
|
|
EID: 53149085293
PISSN: 13697056
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (4)
|
|
References (0)
|
